source: WorldVistAEHR/trunk/r/ONCOLOGY-ONC/ONCSSF5.m@ 1800

Last change on this file since 1800 was 613, checked in by George Lilly, 15 years ago

initial load of WorldVistAEHR
File size: 4.6 KB
Line 
1ONCSSF5 ;Hines OIFO/GWB - SITE-SPECIFIC FACTOR 5 (165.5,44.5) ;11/20/03
2 ;;2.11;ONCOLOGY;**40**;Mar 07, 1995
3 ;
4 ;SITE-SPECIFIC FACTOR 5 (165.5,44.5)
5SSF5IT ;INPUT TRANSFORM
6 ;
7 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
8 I PS="" K X W " No PRIMARY SITE defined for this primary" Q
9 S MO=$$HIST^ONCFUNC(D0)
10 ;
11 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-5")):$O(^ONCO(164.52,"C",PS_"-5",0)),1:1)
12 ;
13 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
14 I $$MELANOMA^ONCOU55(D0) D
15 .S MELIEN=$O(^ONCO(164.52,"B","LDH",0))
16 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
17 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
18 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
19 .I PS=67632 S SSFIEN=MELIEN Q
20 ;
21 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
22 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
23 ;
24 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
25 ;Kaposi Sarcoma of All Sites
26 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
27 ;
28 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
29 ;Myeloproliferative Neoplasms
30 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
31 ;
32 ;Retinoblastoma
33 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
34 ;
35 I '$D(^ONCO(164.52,SSFIEN,1,"B",X)) K X Q
36 S SSF=$O(^ONCO(164.52,SSFIEN,1,"B",X,0))
37 W " ",$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,2)
38ITEX K PS,SSFIEN,SSF,MO,MELING Q
39 ;
40SSF5OT ;OUTPUT TRANSFORM
41 ;
42 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
43 Q:PS=""
44 S MO=$$HIST^ONCFUNC(D0)
45 ;
46 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-5")):$O(^ONCO(164.52,"C",PS_"-5",0)),1:1)
47 ;
48 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
49 I $$MELANOMA^ONCOU55(D0) D
50 .S MELIEN=$O(^ONCO(164.52,"B","LDH",0))
51 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
52 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
53 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
54 .I PS=67632 S SSFIEN=MELIEN Q
55 ;
56 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
57 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
58 ;
59 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
60 ;Kaposi Sarcoma of All Sites
61 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
62 ;
63 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
64 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
65 ;
66 ;Retinoblastoma
67 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
68 ;
69 S SSF=$O(^ONCO(164.52,SSFIEN,1,"B",Y,0)) I SSF="" G OTEX
70 S Y=$P($G(^ONCO(164.52,SSFIEN,1,SSF,0)),U,2)
71OTEX K PS,SSFIEN,SSF,MO Q
72 ;
73SSF5HP ;HELP
74 ;
75 S PS=$P($G(^ONCO(165.5,D0,2)),U,1)
76 Q:PS=""
77 S MO=$$HIST^ONCFUNC(D0)
78 ;
79 S SSFIEN=$S($D(^ONCO(164.52,"C",PS_"-5")):$O(^ONCO(164.52,"C",PS_"-5",0)),1:1)
80 ;
81 ;Malignant Melanoma of Skin, Vulva, Penis, Scrotum
82 I $$MELANOMA^ONCOU55(D0) D
83 .S MELIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
84 .I $E(PS,3,4)=44 S SSFIEN=MELIEN Q
85 .I $E(PS,3,4)=51 S SSFIEN=MELIEN Q
86 .I $E(PS,3,4)=60 S SSFIEN=MELIEN Q
87 .I PS=67632 S SSFIEN=MELIEN Q
88 ;
89 ;Hodgkin and Non-Hodgkin Lymphomas of All Sites
90 I $$LYMPHOMA^ONCFUNC(D0) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
91 ;
92 ;Mycosis Fungoides and Sezary Disease of Skin, Vulva, Penis, Scrotum
93 ;Kaposi Sarcoma of All Sites
94 I (MO=97003)!(MO=97013)!($E(MO,1,4)=9140) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
95 ;
96 ;Hematopoietic, Reticuloendothelial, Immunoproliferative, and
97 I (MO'<97310)&(MO'>99899) S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
98 ;
99 ;Retinoblastoma
100 I $E(MO,1,3)=951 S SSFIEN=$O(^ONCO(164.52,"B","NOT APPLICABLE FOR THIS SITE",0))
101 ;
102 W !," SITE-SPECIFIC FACTOR 5 for " D
103 .I MO=97003 W "MYCOSIS FUNGOIDES of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
104 .I MO=97013 W "SEZARY SYNDROME of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
105 .I $E(MO,1,3)=951 W "RETINOBLASTOMA of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
106 .I $$MELANOMA^ONCOU55(D0),($E(PS,3,4)=44)!($E(PS,3,4)=51)!($E(PS,3,4)=60)!(PS=67632)!($E(PS,3,4)=69) W "MALIGNANT MELANOMA of ",$P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")" Q
107 .I $E(MO,1,4)=9140 W "KAPOSI SARCOMA of ALL SITES" Q
108 .I $$LYMPHOMA^ONCFUNC(D0) W "HODGKIN AND NON-HODGKIN LYMPHOMAS of ALL SITES" Q
109 .I (MO'<97310)&(MO'>99899) W $P(^ONCO(169.3,MO,0),U,1)," (",$P(^ONCO(169.3,MO,0),U,2),")" Q
110 .W $P(^ONCO(164,PS,0),U,1)," (",$P(^ONCO(164,PS,0),U,2),")"
111 W !," ",$P(^ONCO(164.52,SSFIEN,0),U,1)
112 ;S SSF=0 F S SSF=$O(^ONCO(164.52,SSFIEN,1,SSF)) Q:SSF'>0 D
113 ;.S TAB=6
114 ;.W " ",$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,1),?TAB,$P(^ONCO(164.52,SSFIEN,1,SSF,0),U,2),!
115 K PS,SSFIEN,SSF,MO Q
Note: See TracBrowser for help on using the repository browser.